-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders: Poster II

Symposia: Lymphocytes and Acquired or Congenital Immunodeficiency Disorders Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Daigo Michimata1*, Hiroki Kato1*, Naoya Morota1*, Yuya Tanaka, MD1*, Kazuki Sakurai1*, Kazuki Hashimoto1*, Koichi Onodera, MD1*, Shunsuke Hatta1*, Yasushi Onishi1*, Noriko Fukuhara, MD, PhD2 and Hideo Harigae, MD, PhD1

1Department of Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan
2Department of Hematology, Tohoku University School of Medicine, Sendai, Japan

Mohamed Khalil, BS1, Scott Terhune, PhD2* and Subramaniam Malarkannan, PhD2,3,4

1Medical College of Wisconsin, Brookfield, WI
2Microbiology & Immunology, Medical College of Wisconsin, Milwaukee, WI
3Department of Medicine, Versiti, Wisconsin, Milwaukee, WI
4Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Kevin Jan Jan Legscha1*, Lea Philine Märker1*, Najla Abassi, M.Sc.2*, Abdul Yilmaz, M.Sc.1*, Catherine Woelfel, PhD1*, Edite Antunes Ferreira1*, Annekathrin Nedwed, M.Sc.2*, Sara Salome Helbich, M.Sc.3*, Michael Delacher, Prof.3*, Federico Marini, PhD3,4*, Stefan Porubsky, Prof.5*, Matthias Theobald, MD, Prof.1,3,6 and Hakim Echchannaoui, PhD1,6*

1Department of Hematology and Oncology, University Medical Center (UMC), Mainz, Germany
2Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center (UMC), Mainz, Germany
3Institute of Immunology, Research Center for Immunotherapy (FZI), University Medical Center (UMC), Mainz, Germany
4Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center (UMC) Mainz, Mainz, Germany
5Institute of Pathology, University Medical Center (UMC), Mainz, Germany
6Partner site Frankfurt/Mainz, German Cancer Consortium (DKTK), Mainz, Germany

Zin Aung J Soe1*, Ahmed Eldarwi, MBBS1*, Ethan Troy-Barnes, MBBchBAO MRCP FRCPath2*, Rahi Patel3*, Dario Melotti, MBBS4*, Anish Tailor, PharmD3 and Samah Alimam, MD, PhD5*

1Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
2University College London Hospital, London, United Kingdom
3Haematology, University College London Hospitals NHS Foundation Trust, LONDON, United Kingdom
4University College London Hospitals NHS Foundation Trust, LONDON, United Kingdom
5Department of Haematology, University College Hospital, University College of London Hospitals NHS Foundation Trust, London, United Kingdom

Pratik Vikhe, PhD1*, Silas Ferrao2* and Lyn Jones, PhD2*

1Center for Protein Degradation, Dana Farber Cancer Insitute, Boston, MA
2Center for Protein Degradation, Dana Farber Cancer Institute, Boston, MA

Joseph Elengickal, MD1*, Aditya Sood, MD2*, Michael Pavy, DO1*, Lilly Hou, MD3*, Wint Yan Aung, MD3, Vivek Varughese, MD1*, Anish Sangari, MD4*, Cody Cooper, DO1* and Suzanne Fanning, DO5

1Prisma Health - University of South Carolina, Columbia, SC
2Zucker School of Medicine at Hofstra/Northwell Residency at NS/LIJ, Manhasset, NY
3Donald and Barbara Zucker School of Medicine at Hofstra Northwell, Hempstead, NY
4Emory University School of Medicine, Atlanta, GA
5Greenville Health System Cancer Institute, Greenville, SC

Emily M Harris, MD1,2, Sarah Chamseddine, MD2,3*, Matthew Nikiciuk, BS3*, Aleksandra Bourdine, HBSc3*, Logan Magin, BS3*, Brenna Labere, MD4*, Rachael F. Grace, MD, MMSc1,2 and Janet Chou, MD2,3*

1Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA
2Harvard Medical School, Boston, MA
3Division of Immunology, Boston Children's Hospital, Boston, MA
4Divison of Immunology, Phoenix Children's Hospital, Phoenix, AZ

Dawlat Khan, MBBS1*, Muhammad Ammar Bin Hamid, MBBS1*, Dawood Shehzad, MBBS1*, Hammad Chaudhry, MBBS1*, Rafia Waheed, MBBS1*, Mamoon Ahmed, MBBS1* and Hafez Ammar Abdullah, MBBS2

1Internal Medicine, University of South Dakota Sanford School of Medicine, Sioux Falls, SD
2Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE

*signifies non-member of ASH